TCL Archive Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response December 28, 2012
TCL Archive Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds August 26, 2005
TCL Archive Oklahoma’s new cigarette tax will provide $7 million a year to the University of Oklahoma Cancer Center. November 5, 2004
TCL Archive Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer March 26, 2010